| Boston Scientific acquires Calif. firm for up to $160M Boston Scientific is showing no signs of slowing its aggressive acquisition strategy as the medical device giant is set to acquire a privately held obstructive disease firm for up to $160 million. Alzheon researchers discover key Alzheimer's substance Researchers at the Framingham pharmaceutical firm Alzheon have discovered a substance in the brain inhibiting the formation of molecules that help form Alzheimer's disease. Acacia expecting normal Q3 operations with ZTE back Shares of Acacia Communications have jumped nearly 20 percent since it said the business will get back on track with its largest customer allowed back into U.S. commerce. Virtusa reports 32% revenue bump, but $7.4M in Q1 losses Southborough global IT firm Virtusa is facing a $7.4-million loss in its first quarter despite its revenues jumping 32 percent year-over-year and 6.6 percent sequentially. | 
Like us on Facebook for our latest business news
